Elequin Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Elequin Capital's AMPH Position: Q2 2026 in Review
Elequin Capital increased its Amphastar Pharmaceuticals (AMPH) stake by 57% in Q2 2026, buying an estimated $81 and bringing the position to 11 shares worth $222. The position accounts for ﹤0.01% of the portfolio, ranked #639.
Elequin Capital first reported a position in AMPH in Q1 2024 and has held it in 6 quarters since. The position peaked at $4.83K in Q1 2024. 212 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Elequin Capital held 11 shares of Amphastar Pharmaceuticals worth $222 as of Q2 2026.
- Elequin Capital bought 4 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $81.
- Amphastar Pharmaceuticals made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #639 holding.
- Elequin Capital first reported a position in Amphastar Pharmaceuticals in Q1 2024 and has held it in 6 quarters since.
- Elequin Capital's Amphastar Pharmaceuticals position peaked at $4.83K in Q1 2024.
- 212 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.